Skip to content
Biodatica
Start free

Investigator

Krista Maurine Lisdahl

UNIVERSITY OF WISCONSIN MILWAUKEE · funded by NIDA

Companies
2

Resolved onto their grants.

Grants
4

Federal awards on file.

Non-dilutive funding
$3.6M

Summed across those awards.

First award
Jul 15, 2017

Latest Jul 1, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Examining the longitudinal impact of circulating endocannabinoid levels on neurocognition, impulsivity, and early cannabis use patterns in youth enrolled in the ABCD Study

    $621k

    Jul 1, 2025NIDAUNIVERSITY OF WISCONSIN MILWAUKEENIH RePORTER · 11243055 (opens the source filing in a new tab)

  2. R01

    Examining the longitudinal impact of circulating endocannabinoid levels on neurocognition, impulsivity, and early cannabis use patterns in youth enrolled in the ABCD Study

    $568k

    Jul 1, 2025NIDAUNIVERSITY OF WISCONSIN MILWAUKEENIH RePORTER · 11359703 (opens the source filing in a new tab)

  3. U01

    11/21 ABCD-USA Consortium: Research Project Site at UWM

    $1.2M

    Jul 15, 2017NIDAUNIVERSITY OF WISCONSIN MILWAUKEENIH RePORTER · 11078197 (opens the source filing in a new tab)

  4. U01

    11/21 ABCD-USA Consortium: Research Project Site at UWM

    $1.2M

    Jul 15, 2017NIDAUNIVERSITY OF WISCONSIN MILWAUKEENIH RePORTER · 11302694 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources